Clopidogrel application: Beyond coronary artery disease

Clinical Science

Volumn 118, Issue 7, 2010, Pages 459-461

  Zeng, Chunyu ^a,b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Shantou Medical College   (China)

Author keywords

ADP; Angiotensin II; Clopidogrel; Endothelium; Hypertension; Mesenteric artery; P2Y receptor

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; ANGIOTENSIN II; CLOPIDOGREL; METOPROLOL; PHENYLEPHRINE; PLACEBO; TICLOPIDINE; P2Y12 PROTEIN, RAT; PURINERGIC P2 RECEPTOR;

ARTICLE; BLEEDING DISORDER; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; DIABETIC PATIENT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; HEART INFARCTION; HUMAN; HYPERTENSION; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; SPRAGUE DAWLEY RAT; UNSPECIFIED SIDE EFFECT; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; MALE; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; HYPERTENSION; MALE; MESENTERIC ARTERIES; RECEPTORS, PURINERGIC P2; TICLOPIDINE;

EID: 74749105330     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20090546     Document Type: Article

References (10)

1. Wallentin, L. (2009) P2Y12 inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use. Eur. Heart J. 30, 1964-1977
2. Michelson, A. D. (2008) P2Y12 antagonism: promises and challenges. Arterioscler. Thromb. Vasc. Biol. 28, s33-s38
3. Ling, G. and Ovbiagele, B. (2009) Oral antiplatelet therapy in the secondary prevention of atherothrombotic events. Am. J. Cardiovasc. Drugs 9, 197-209
4. Patel, J. H., Stoner, J. A., Owora, A., Mathew, S. T. and Thadani, U. (2009) Evidence for using clopidogrel alone or in addition to aspirin in post coronary artery bypass surgery patients. Am. J. Cardiol. 103, 1687-1693
5. Usman, M. H., Notaro, L. A., Nagarakanti, R., Brahin, E., Dessain, S., Gracely, E. and Ezekowitz, M. D. (2009) Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble? Am. J. Cardiol. 103, 1107-1112
6. Mohler, III, E. R. (2009) Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?Catheter. Cardiovasc. Interv. 74, (Suppl. 1), S1-S6
7. Giachini, F. R. C., Osmond, D. A., Zhang, S., Carneiro, F. S., Lima, V. V, Inscho, E. W.,Webb, R. C. and Tostes, R. C. (2010) Clopidogrel, independent of the vascular P2Y12 receptor, improves arterial function in small mesenteric arteries from AngII-hypertensive rats. Clin. Sci. 118, 463-471
8. Warnholtz, A., Ostad, M. A., Velich, N., Trautmann, C., Schinzel, R., Walter, U. and Munzel, T. (2008) A single loading dose of clopidogrel causes dose-dependent improvement of endothelial dysfunction in patients with stable coronary artery disease: results of a double-blind, randomized study. Atherosclerosis 196, 689-695
9. Steinhubl, S. R., Badimon, J. J., Bhatt, D. L., Herbert, J. M. and Lüscher, T. F. (2007) Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease. Vasc. Med. 12, 113-122
10. Heitzer, T., Rudolph, V., Schwedhelm, E., Karstens, M., Sydow, K., Ortak, M., Tschentscher, P., Meinertz, T., Böger, R. and Baldus, S. (2006) Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects. Arterioscler. Thromb. Vasc. Biol. 26, 1648-1652